Funding
Series B · Biotech

CREATE Medicines raises $122M Series B

CREATE Medicines raised $122 million in Series B financing announced in May.

Updated Oct 16, 2026By RoundOS Funding desk

Newpath Partners, ARCH Venture Partners, Hatteras Venture Partners and Alexandria Venture Investments are among its backers.

The company develops an in vivo immune-programming platform for repeat-dose immunotherapies.

Funding history

Series B · This round$122M

Sources

  1. CREATE Medicinesprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related